Heather Lipkind, MD
Professor AdjunctDownloadHi-Res Photo
About
Titles
Professor Adjunct
Biography
Dr. Lipkind graduated from Wesleyan University where she received a B.A. in Biology. She went on to earn her M.D. degree from Weill Cornell Medical College in New York City. She completed her residency in OB/GYN at New York University. She completed her Maternal-fetal Medicine fellowship at Columbia University in 2006 and her Master’s in Clinical Epidemiology from the Mailman School of Public Health during her Fellowship. Dr. Lipkind worked as a Perinatal Epidemiology Consultant at the New York City Department of Health and Mental Hygiene from 2006-2010. She is interested in outcomes research and population based epidemiology.
Last Updated on January 11, 2023.
Departments & Organizations
- Maternal-Fetal Medicine
- Prenatal Genetic Diagnosis Program
- Yale Hearts Moms (Lipkind Lab)
- Yale Ventures
Education & Training
- Fellow
- Columbia University College of Physicians and Surgeons (2006)
- MS
- Mailman School of Public Health (2005)
- Fellow
- Brown University (2004)
- Resident
- New York University School of Medicine (2003)
- MD
- Cornell University Medical College (1999)
- BA
- Wesleyan University (1994)
Research
Research at a Glance
Yale Co-Authors
Frequent collaborators of Heather Lipkind's published research.
Annalies Denoble, MD, MSc
Erica Spatz, MD, MHS
Jennifer Nelson
Sangini S. Sheth, MD, MPH, FACOG
Allison E. Gaffey, PhD, FAHA
Ariadna Forray, MD
Publications
2025
Coronavirus Disease 2019 (COVID-19) Vaccination and Spontaneous Abortion
Sheth S, Vazquez-Benitez G, DeSilva M, Zhu J, Seburg E, Denoble A, Daley M, Getahun D, Klein N, Vesco K, Irving S, Nelson J, Williams J, Hambidge S, Donahue J, Lipkind H, Kharbanda E. Coronavirus Disease 2019 (COVID-19) Vaccination and Spontaneous Abortion. Obstetrics And Gynecology 2025, 146: 129-137. PMID: 40311142, PMCID: PMC12169859, DOI: 10.1097/aog.0000000000005904.Peer-Reviewed Original ResearchAltmetricMeSH Keywords and ConceptsConceptsSpontaneous abortionVaccine Safety Datalink sitesLive birthsCase groupGestational ageCOVID-19 vaccineDose numberContinuous health plan enrollmentPregnancy start dateControl groupCase-control studyHealth plan enrollmentSafety of COVID-19 vaccinesConditional logistic regressionSingleton pregnanciesFetal deathPregnancy outcomesPrenatal visitEarly pregnancyMaternal agePregnancyVaccine exposureOutcome datePatientsPlan enrollmentOne Step Closer to Unlocking Preeclampsia Prevention
Ackerman-Banks C, Spatz E, Lipkind H. One Step Closer to Unlocking Preeclampsia Prevention. Journal Of The American College Of Cardiology 2025, 85: 1501-1503. PMID: 40204379, DOI: 10.1016/j.jacc.2025.03.455.Peer-Reviewed Original ResearchCitationsClosing the Gap: Digital Innovations to Address Hypertension Disparities
Shanab B, Gaffey A, Schwamm L, Zawalich M, Sarpong D, Pérez-Escamilla R, Dorney J, Cooperman C, Schafer R, Lipkind H, Lu Y, Onuma O, Spatz E. Closing the Gap: Digital Innovations to Address Hypertension Disparities. Current Cardiology Reports 2025, 27: 23. PMID: 39812880, DOI: 10.1007/s11886-024-02171-x.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsConceptsHypertension disparitiesCare teamSocial determinants of healthCommunity health workersDeterminants of healthRemote blood pressure monitoringIncrease patient empowermentBlood pressure controlMultidisciplinary care teamBlood pressure machineIntegration of servicesHealth equityHealth inequalitiesHealth disparitiesPatient empowermentPatient engagementInfluence blood pressure controlSocial determinantsHealth workersTelehealth visitsPayment modelsHypertension managementPressure controlHypertension DetectionPatient outcomesPrevalence of GLP-1 medication exposure prior to, during, and after pregnancy using state-wide data from 2017 to 2023
Ahrens K, Palmsten K, Lipkind H, Ackerman-Banks C. Prevalence of GLP-1 medication exposure prior to, during, and after pregnancy using state-wide data from 2017 to 2023. American Journal Of Obstetrics & Gynecology MFM 2025, 7: 101596. PMID: 39755252, DOI: 10.1016/j.ajogmf.2024.101596.Peer-Reviewed Original Research
2024
Ambulatory care utilization in the first 24 months’ postpartum by rurality and pregnancy‐related conditions: A prospective cohort study from Maine
Bebus S, Palmsten K, Lipkind H, Ackerman‐Banks C, Ahrens K. Ambulatory care utilization in the first 24 months’ postpartum by rurality and pregnancy‐related conditions: A prospective cohort study from Maine. The Journal Of Rural Health 2024, 41: e12912. PMID: 39722432, DOI: 10.1111/jrh.12912.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsConceptsPregnancy-related conditionsRate of visitsCare usePostpartum personsAmbulatory careMonths postpartumAcute health care useRate ratiosRurality of residenceHealth care useAmbulatory care visitsAmbulatory care utilizationAmbulatory care useAmbulatory care accessRural areasHypertensive disorders of pregnancyProspective cohort studyMonthly rateCare visitsPrenatal depressionCare accessCare utilizationDisorders of pregnancyMonthly rate of visitsPoisson regressionCOVID-19 Vaccination in the First Trimester and Major Structural Birth Defects Among Live Births
Kharbanda E, DeSilva M, Lipkind H, Romitti P, Zhu J, Vesco K, Boyce T, Daley M, Fuller C, Getahun D, Jackson L, Williams J, Zerbo O, Weintraub E, Vazquez-Benitez G. COVID-19 Vaccination in the First Trimester and Major Structural Birth Defects Among Live Births. JAMA Pediatrics 2024, 178: 823-829. PMID: 38949821, PMCID: PMC11217887, DOI: 10.1001/jamapediatrics.2024.1917.Peer-Reviewed Original ResearchCitationsAltmetricConceptsStructural birth defectsLive-born infantsFirst-trimesterBirth defectsCOVID-19 vaccineLive birthsRetrospective cohort study of singleton pregnanciesStudy of singleton pregnanciesVaccine exposureMessenger RNA COVID-19 vaccineMessenger RNAFirst-trimester vaccinationMRNA COVID-19 vaccinePrevent pregnancy complicationsRetrospective cohort studyStabilized inverse probability weightsElectronic health dataNeural tube defectsMedical record reviewMultisite cohort studyLMP dateVaccine Safety DatalinkCOVID-19 vaccine dosesSingleton pregnanciesEligible pregnanciesNonadjuvanted Bivalent Respiratory Syncytial Virus Vaccination and Perinatal Outcomes
Son M, Riley L, Staniczenko A, Cron J, Yen S, Thomas C, Sholle E, Osborne L, Lipkind H. Nonadjuvanted Bivalent Respiratory Syncytial Virus Vaccination and Perinatal Outcomes. JAMA Network Open 2024, 7: e2419268. PMID: 38976271, PMCID: PMC11231799, DOI: 10.1001/jamanetworkopen.2024.19268.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsRespiratory syncytial virusNeonatal intensive care unitPreterm birthWeeks gestationRisk of HDPPerinatal outcomesLogistic regression modelsIncreased riskPregnant individualsPrenatal vaccinationSmall-for-gestational age birth weightNeonatal intensive care unit admissionCohort studyIncreased risk of PTBOdds ratioIncreased risk of HDPRisk of preterm birthRespiratory syncytial virus seasonRespiratory syncytial virus vaccineRetrospective observational cohort studyNeonatal respiratory distressVaccination statusMultivariate logistic regression modelObservational cohort studyCox regression modelsDoes reversible postpartum contraception reduce the risk of pregnancy condition recurrence? A longitudinal claims-based study from Maine
Ahrens K, Palmsten K, Lipkind H, Ackerman-Banks C, Grantham C. Does reversible postpartum contraception reduce the risk of pregnancy condition recurrence? A longitudinal claims-based study from Maine. Annals Of Epidemiology 2024, 96: 58-65. PMID: 38885800, PMCID: PMC11283344, DOI: 10.1016/j.annepidem.2024.06.001.Peer-Reviewed Original ResearchConceptsDays of deliveryPostpartum contraceptive useInterpregnancy intervalPregnancy conditionsReversible contraceptionPrenatal depressionRisk of prenatal depressionContraceptive useShort interpregnancy intervalAssociated with recurrenceRisk of recurrenceAssociated with lower riskLog-binomial regression modelsModerately effective methodsEstimate risk ratiosHypertensive disordersIndex pregnancyPostpartum contraceptionPregnancy deliveryClaims-based studyGestational diabetesIntrauterine deviceIntrapartum periodContraceptive initiationPregnancyCoronavirus Disease 2019 (COVID-19) Vaccination and Stillbirth in the Vaccine Safety Datalink
Denoble A, Vazquez-Benitez G, Sheth S, Ackerman-Banks C, DeSilva M, Zhu J, Daley M, Getahun D, Klein N, Vesco K, Irving S, Nelson J, Williams J, Hambidge S, Donahue J, Weintraub E, Kharbanda E, Lipkind H. Coronavirus Disease 2019 (COVID-19) Vaccination and Stillbirth in the Vaccine Safety Datalink. Obstetrics And Gynecology 2024, 144: 215-222. PMID: 38843526, PMCID: PMC11250101, DOI: 10.1097/aog.0000000000005632.Peer-Reviewed Original ResearchCitationsAltmetricConceptsVaccine Safety DatalinkAntepartum stillbirthVaccine Safety Datalink sitesLive birthsCOVID-19 vaccineVaccine dosePregnancy start dateRisk of severe morbidityRisk of stillbirthConditional logistic regressionCase-control studyVaccine manufacturersSingleton pregnanciesGestational ageFetal deathPostpartum visitMaternal ageIndex dateSevere morbidityDiagnostic codesPregnancyStillbirthPregnant peopleCOVID-19Logistic regressionAssociation Between Hypertensive Disorders of Pregnancy and Cardiovascular Diseases Within 24 Months After Delivery
Ackerman-Banks C, Lipkind H, Palmsten K, Ahrens K. Association Between Hypertensive Disorders of Pregnancy and Cardiovascular Diseases Within 24 Months After Delivery. Obstetric Anesthesia Digest 2024, 44: 72-73. DOI: 10.1097/01.aoa.0001015964.97203.7e.Peer-Reviewed Original ResearchAltmetricConceptsHypertensive disease of pregnancyIncreased risk of long-term morbidityHypertensive disorders of pregnancyRisk of long-term morbidityDisease of pregnancyDisorders of pregnancyLong-term morbidityImmediate postpartum periodCardiovascular diagnosisHypertensive disordersIncreased riskPostpartum periodHypertensive diseaseCardiovascular diseaseCVD outcomesRisk profilePregnancyMonthsDiagnosisRiskDeliveryAssociationMorbidity
Clinical Trials
Current Trials
Aspirin to Prevent Preeclampsia in Women With Elevated Blood Pressure and Stage 1 Hypertension (ASPPIRE)
HIC ID2000028023RoleSub InvestigatorPrimary Completion Date07/31/2022Recruiting ParticipantsGenderFemaleAge18+ yearsSupport Models for Addiction Related Treatment (SMART) Trial of Opioid Use Disorder in Pregnant Women
HIC ID2000027031RoleSub InvestigatorPrimary Completion Date04/28/2023Recruiting ParticipantsGenderFemaleAge18+ yearsChronic Hypertension and Pregnancy (CHAP) Project (CHAP)
HIC ID2000024291RoleSub InvestigatorPrimary Completion Date12/31/2020Recruiting ParticipantsGenderFemaleAge12+ years